Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis-Reference-Cited by-同舟云学术

Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis

Published:2019-02 Issue:2 Volume:157 Page:743-753.e3
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Brandt Whitney S.,Yan Wanpu,Zhou Jian,Tan Kay See,Montecalvo Joseph,Park Bernard J.,Adusumilli Prasad S.,Huang James,Bott Matthew J.,Rusch Valerie W.,Molena Daniela,Travis William D.,Kris Mark G.,Chaft Jamie E.,Jones David R.

Funder

National Institutes of Health

National Cancer Institute

AstraZeneca

Genentech

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference28 articles.

1. Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma;Brandt;J Thorac Cardiovasc Surg,2018

2. Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients;Berry;Ann Surg Oncol,2015

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J Clin Oncol,2008

4. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis;Value in Health Regional Issues;2024-05

2. Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis;JNCI Cancer Spectrum;2024-03-23

3. Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process;Current Oncology;2023-12-06

4. Genomic profiling and metastatic risk in early-stage non–small cell lung cancer;JTCVS Open;2023-12

5. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives;Journal of Thoracic Oncology;2023-11